Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120555388A reveals enhanced leucine dehydrogenase mutants for high-purity L-phenylglycine synthesis, offering significant supply chain and cost advantages.
Novel transaminase mutant CN113621592A enables 99% yield of L-glufosinate. Reduces cost and improves supply chain reliability for agrochemical intermediates.
Patent CN101260415A reveals high-efficiency biocatalytic route for chiral intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106434611A details a high-yield enzymatic route for L-Ornithine, offering superior purity and supply chain stability for nutritional and pharmaceutical applications.
Patent CN110527646B reveals a novel Bacillus tropicalis strain for high-purity S-isomer production. Discover cost-effective agrochemical intermediate manufacturing solutions.
Patent CN106497843B reveals high-purity biocatalytic route. Reduces costs and enhances supply chain reliability for diabetes drug intermediates.
Novel biocatalytic route for (R)-1-(4-bromophenyl)-2,2,2-trifluoroethanol using Cyberlindnera saturnus. High ee, mild conditions, scalable pharma intermediate production.
Patent CN113462728A details a novel whole-cell biocatalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112048538B reveals a high-yield biocatalytic route for Aprepitant intermediates using Cyberlindnera saturns, offering superior purity and cost efficiency.
Patent CN113754673A details a green enzymatic route for indoline isochroman derivatives, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Novel carbonyl reductase mutants enhance thermal stability and yield for pharmaceutical intermediates like florfenicol and statins, offering cost-effective biocatalytic solutions.
Patent CN104630242B reveals novel biocatalytic routes for chiral intermediates. Enhances supply chain reliability and reduces heavy metal dependency in manufacturing.
Patent CN102517361A details lipase-catalyzed arbutin synthesis offering mild conditions and high purity for reliable cosmetic ingredient supply chains.
Patent CN117089533A details novel carbonyl reductase mutants enabling cost reduction in chiral alcohol manufacturing with high stereoselectivity and supply reliability.
Patent CN114686451A discloses amine dehydrogenase mutants for high-yield production. Offers cost reduction in pharma intermediate manufacturing with >99% ee.
Novel recombinant E. coli route for D-HPG production offers cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN118895266A reveals enzymatic synthesis of L-2-aminobutyric acid. Achieve >99% conversion with reduced environmental impact for levetiracetam production.
Patent CN106190910A reveals novel Bacillus anthracis method. Enhances solubility and conversion. Reliable supply chain for pharmaceutical intermediates.
Patent CN101205548B reveals immobilized yeast method for high-purity fluoxetine intermediate with superior stereoselectivity and scalability.
Patent CN119823960B discloses mutants for L-glufosinate. Improves efficiency and purity for agrochemical intermediate manufacturing supply chains.